31, 2024 /PRNewswire/ -- Michael Greger, M.D., FACLM, the internationally renowned nutrition expert, physician, founder of NutritionFacts.org, and author of the best-selling books How Not to Die , How Not to Diet , and How Not to Age , turned his attention to the latest research on GLP-1 weight-loss drugs in his new book, OZEMPIC: Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs (Oct 29, 2024), available now on Amazon in softcover and Kindle versions, and on DrGreger.org as an audiobook and ebook
First, tesamorelin carries a real, trial-documented glucose signal : because it works through GH and IGF-1, it can affect glucose handling, and its labeling reflects contraindications such as active malignancy, disruption of the pituitary/HPA axis, and pregnancy
MIS-C might be rare but it is serious
How long are you willing to invest before expecting returns